Development of a condition-specific patient-reported outcome measure for measuring treatment outcome in peripheral Vascular Malformations: the OVAMA Treatment Outcome questionnaire
Clicks: 3
ID: 315289
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #204 of 313 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 313 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The treatment of vascular malformations is aimed at improving symptoms; therefore, evaluating treatment from the patient's perspective is crucial. In this study, we report the development of the patient-reported outcome measure, the OVAMA Treatment Outcome questionnaire, which assesses treatment and outcomes in patients with vascular malformations. Additionally, we found that the OVAMA Treatment Outcome questionnaire has good content and construct validity.
| Reference Key |
openalex_W7162756837
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Merel L E Stor, Max M Lokhorst, Sophie E R Horbach, J G Annerruth Eits, Michael A J Luijten, Lotte Haverman, Chantal M A M van der Horst |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag208
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.